Stephen W. Kaldor
Gründer bei Fount Therapeutics LLC
Profil
Stephen W.
Kaldor founded Fount Therapeutics LLC in 2016, where he is working as Chief Executive Officer & Director from 2016, Kinnate Biopharma, Inc. in 2018, where he worked as Director from 2020 to 2021, and XinThera, Inc. in 2021, where he worked as Chairman.
Dr. Kaldor also currently works at Resolute Therapeutics, Inc., as Director from 2016.
Dr. Kaldor also formerly worked at Ambrx, Inc., as President & Chief Executive Officer, Quanticel Pharmaceuticals, Inc., as President, Chief Executive Officer & Director from 2013 to 2015, Amira Pharmaceuticals, Inc., as Director from 2008 to 2011, Furiex Pharmaceuticals, Inc., as Independent Director from 2012 to 2014, Bird Rock Bio, Inc., as Director, Crinetics Pharmaceuticals, Inc., as Independent Director from 2015 to 2021, Eli Lilly & Co., as Principal from 1989 to 2001, Syrrx, Inc., as President & Chief Scientific Officer in 2005, Versant Venture Management LLC, as Venture Partner, and Takeda San Diego, Inc., as President & Chief Scientific Officer.
Dr. Kaldor received his undergraduate degree from The Trustees of Columbia University in The City of New York and doctorate degree in 1989 from Harvard University.
Aktive Positionen von Stephen W. Kaldor
| Unternehmen | Position | Beginn |
|---|---|---|
Fount Therapeutics LLC
 Fount Therapeutics LLC Pharmaceuticals: MajorHealth Technology Fount Therapeutics LLC operates a drug discovery enterprise. The company was founded by Eric Murphy and Steve W. Kaldor and is headquartered in San Marcos, CA. | Gründer | 01.12.2016 |
Resolute Therapeutics, Inc.
 Resolute Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Resolute Therapeutics, Inc. operates as a biotechnology company. The private company is based in Winston-Salem, NC. | Direktor/Vorstandsmitglied | 01.10.2016 |
Ehemalige bekannte Positionen von Stephen W. Kaldor
| Unternehmen | Position | Ende |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 22.06.2021 |
| KINNATE BIOPHARMA INC. | Vorstandsvorsitzender | - |
Quanticel Pharmaceuticals, Inc.
 Quanticel Pharmaceuticals, Inc. BiotechnologyHealth Technology Quanticel Pharmaceuticals, Inc. engaged in the development of medicines for the treatment of cancer. The company was founded by Stephen Quake and Michael Clarke in 2010 and was headquartered in San Francisco, CA. | Vorstandsvorsitzender | 01.10.2015 |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Corporate Officer/Principal | 01.10.2015 |
| FURIEX PHARMACEUTICALS INC | Direktor/Vorstandsmitglied | 02.07.2014 |
Ausbildung von Stephen W. Kaldor
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| Harvard University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| CRINETICS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 12 |
|---|---|
Syrrx, Inc.
 Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Syrrx, Inc. used to develops drugs. Its focus was on creating novel therapies for cancer, metabolic diseases and inflammation. The company was the technology leader in the field of structural proteomics, the process of generating protein structures from genetic information. It was headquartered in San Diego, CA | Health Technology |
Amira Pharmaceuticals, Inc.
 Amira Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 2005 and headquartered in San Diego, Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory and fibrotic diseases. Amira combines the rigor of a big pharmaceutical company with the ingenuity and energy of a small company, creating an environment for efficient development of novel compounds and effective pre-clinical and clinical program decisions. The firm's team is building on unparalleled insights into bioactive lipid pathways and complex signaling processes controlling many conditions including asthma, chronic obstructive pulmonary disease, cardiovascular and various fibrotic diseases. Amira has a partnership with GlaxoSmithKline for the development of FLAP (5-lipoxygenase activating protein) inhibitors in respiratory and cardiovascular disease. | Health Technology |
Furiex Pharmaceuticals, Inc.
 Furiex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Furiex Pharmaceuticals, Inc. operates as a drug development collaboration company that uses innovative clinical development design to accelerate and increase value of drug development programs by advancing them through the drug discovery and development process in a cost-efficient manner. Its drug development programs are designed and driven by a core team with extensive drug development experience. Furiex Pharmaceuticals was founded in 1998 and is headquartered in Morrisville, NC. | Health Technology |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Finance |
Ambrx, Inc.
 Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
Takeda San Diego, Inc.
 Takeda San Diego, Inc. Medical DistributorsDistribution Services Takeda San Diego, Inc. discovers drugs for cancer treatment. It integrates protein crystallography and drug discovery technologies to generate Investigational New Drug (IND) candidates for the treatment of metabolic diseases and cancer. The company was founded in 1781 and is headquartered in San Diego, CA. | Distribution Services |
Bird Rock Bio, Inc.
 Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Health Technology |
Quanticel Pharmaceuticals, Inc.
Quanticel Pharmaceuticals, Inc. BiotechnologyHealth Technology Quanticel Pharmaceuticals, Inc. engaged in the development of medicines for the treatment of cancer. The company was founded by Stephen Quake and Michael Clarke in 2010 and was headquartered in San Francisco, CA. | Health Technology |
Fount Therapeutics LLC
Fount Therapeutics LLC Pharmaceuticals: MajorHealth Technology Fount Therapeutics LLC operates a drug discovery enterprise. The company was founded by Eric Murphy and Steve W. Kaldor and is headquartered in San Marcos, CA. | Health Technology |
Resolute Therapeutics, Inc.
Resolute Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Resolute Therapeutics, Inc. operates as a biotechnology company. The private company is based in Winston-Salem, NC. | Commercial Services |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
Xinthera, Inc.
 Xinthera, Inc. Pharmaceuticals: MajorHealth Technology Part of Gilead Sciences, Inc., XinThera, Inc. is a drug discovery company focused on building a small molecule oncology and immunology pipeline. The company is based in San Diego, CA. XinThera is backed by a group of international investors including Foresite Capital, OrbiMed Advisors, LLC, and TTM Capital. XinThera's lead programs focus on well-validated targets with a mission to rapidly create and advance fast-follower programs with potential in areas of high-unmet need. XinThera was founded by Qing Dong, Stephen W. Kaldor, and Gene Hung. The CEO is Christopher C. LeMasters. | Health Technology |
